Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Strem Chemicals - Nanomaterials for R&D
Add Company

There is 1 related live offer.

Save 25% on magneTherm

Enceladus

Kruislaan 406
Amsterdam, 1098 SM
Netherlands
PH: 31 (0) 20 751 20 51
Email: info@enceladus.nl
Visit Enceladus Website or Request Quote for Further Information

Primary Activity

Drug development

Company Background

Enceladus is a young, small-scale drug development company. Enceladus introduced Nanocort, a liposomal pharmaceutical that contains anti-inflammatory corticosteroid and selectively targets the actual sites of pathology in severe inflammatory disorders such as rheumatoid arthritis (RA) and multiple sclerosis (MS), and in cancer. Nanocort may offer a novel, highly effective therapeutic intervention strategy. In a range of experimental disease models it was shown that intravenous treatment results in selective accumulation in diseased areas in the body. Consequently, a dramatic increase in intensity and durability of the therapeutic effect was shown, with minimal adverse effects.

Ask A Question

Do you have a question you'd like to ask this Supplier?

Leave your feedback
Submit